Skip to content
Review Open access

Tembusu virus neuroinvasion and neuropathogenesis: lessons from blood–brain barrier dysfunction in neurotropic flaviviruses

Sep 2026 · Frontiers in Veterinary Science · Vol 13 · 0 citations · 94 references
Medicine

TL;DR

It is argued that TMUV-associated neurological disease should be interpreted along a peripheral-to-CNS sequence that separates CNS access, BBB dysfunction, post-entry brain replication, neuroinflammatory amplification, and clinical disease.

Abstract

Central nervous system (CNS) pathogenesis remains a critical but incompletely resolved aspect of flavivirus infection. Neurotropic flaviviruses usually initiate replication in peripheral tissues but can subsequently access the CNS, causing encephalitis, neurological dysfunction, or developmental abnormalities. Because these events occur along a continuum from peripheral infection to CNS injury, their temporal and mechanistic relationships are often difficult to define. In many studies, brain viral detection, blood–brain barrier (BBB) dysfunction, neuroinflammation, and neurological signs are reported together, although they represent different steps in disease progression. Studies of Japanese encephalitis virus, West Nile virus, Zika virus, dengue virus, and tick-borne encephalitis virus show that BBB dysfunction is an important component of flavivirus-associated neurological disease, but no single conserved mechanism applies across flaviviruses. Endothelial activation, cytokine and chemokine signaling, tight junction remodeling, matrix metalloproteinase activity, leukocyte trafficking, glial inflammatory amplification, and viral genetic variation can each shape barrier-related phenotypes, with distinct timing and relative importance depending on virus species and experimental context. Tembusu virus (TMUV) is an evolving avian flavivirus responsible for widespread waterfowl outbreaks, with ongoing genetic diversification and an expanding recognized host and vector range. Increasing evidence of neurological signs, brain lesions, and viral detection in neural tissues indicates that CNS-associated pathogenicity is an important feature of TMUV infection. However, the routes of TMUV CNS entry, the temporal relationship between BBB dysfunction and early brain infection, the viral genetic basis of strain-dependent neurological phenotypes, and the contribution of host inflammation to BBB injury remain unclear. Here, we review current advances in flavivirus-associated BBB dysfunction and use comparative flavivirus evidence to guide a stage-specific interpretation of TMUV neuroinvasion and neuropathogenesis. We argue that TMUV-associated neurological disease should be interpreted along a peripheral-to-CNS sequence that separates CNS access, BBB dysfunction, post-entry brain replication, neuroinflammatory amplification, and clinical disease. By linking CNS-associated phenotypes to defined disease steps, this approach may help explain the emergence of TMUV strains with enhanced neurological pathogenicity and provide a clearer basis for evaluating attenuation and vaccine safety.

Read PDF

Similar papers

Open access Oct 2026

Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints

Enterovirus A71 (EV-A71) is an important cause of severe neurological complications of hand, foot, and mouth disease in children. Most infections remain confined to peripheral sites, whereas only a small proportion progress to central nervous system (CNS) disease, and the mechanisms underlying this transition remain in...

Yi Zhang, Zhi Li, Yu Gu et al. · 0 citations
Review Open access Oct 2026

From Systemic Infection to Central Nervous System Pathology: Virus-Induced Neuroinflammatory Cascades and Blood–Brain Barrier Disruption

Background: Viral infections are recognized triggers of neurological disease through immune-mediated mechanisms that induce acute and chronic neuroinflammation. Although the central nervous system (CNS) is protected by the blood–brain barrier (BBB), several pathogens can access the CNS through mechanisms including leuk...

Maria-Arsenia Maniori, G. M. Spyrou · 0 citations
Open access Sep 2026

RIPK3 acts as a molecular switch between neuroprotection and neuropathology during herpes simplex encephalitis

Herpes simplex virus type 1 (HSV-1) is the leading cause of sporadic viral encephalitis, where uncontrolled viral replication and neuroinflammation drive fatal brain injury. Inherited RIPK3 deficiency predisposes humans to severe disease, but the protective mechanism remains unclear. Using single-cell transcriptomics,...

Shu-Qi Wang, Jian Wang, Madison Hicks et al. · 0 citations
Open access Sep 2026

Oropouche virus disrupts neurodevelopment and exhibits congenital infection potential

Oropouche virus (OROV) historically caused a self-limiting disease, yet recent strains have been clinically linked to congenital infection and neurodevelopmental disease. These observations highlight the need to study OROV as a congenital pathogen. Here, using both a historical and currently circulating strain, we show...

Carl Bannerman, D. Philip, Elizabeth A. Kennedy et al. · 0 citations
Review Open access Sep 2026

Hantavirus: biology, immune responses, and pathogenesis

This review synthesizes the recent research on hantavirus biology, cellular entry mechanisms, and epidemiological characteristics, and highlights that viral immune evasion and subsequent uncontrolled host immune responses act as the core pathogenic drivers.

Yu-Fang Shi, Mauro Piacentini, A. Zumla et al. · 0 citations
Review Open access Sep 2026

Neurological Complications of Oncogenic Viruses: Mechanisms, Clinical Manifestations, and Emerging Insights.

A comprehensive understanding of the complex interactions between oncogenic viruses, the immune system, and the nervous system will facilitate earlier diagnosis, improve patient management, and support the development of targeted therapeutic approaches for virus-associated neurological disorders.

Lei Liu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.